BusinessColibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI SystemBy Nasdaq OMXMay 4, 2018, 3:09 PM UTC
BusinessInterventional Cardiology Devices Market is projected at a CAGR of 2.9% by 2022, globally: Transparency Market ResearchBy Nasdaq OMXFeb 6, 2018, 12:47 PM UTC
BusinessInterventional Cardiology Devices Market to Stand at US$11.2 bn by 2022, Bioabsorbable Vascular Stents to be Enormous Opportunity: Transparency Market ResearchBy Nasdaq OMXMar 11, 2016, 12:30 PM UTC
